Generation of βA4 from the amyloid protein precursor and fragments thereof

FEBS Letters

Dyrks, Thomas²  Beyreuther, Konrad¹  Dyrks, Elke¹  Mönning, Ulla¹  Turner, Jonathan²  Urmoneit, Britta² 

[1] Center for Molecular Biology, University of Heidelberg, Heidelberg, Germany;Research Laboratories of Schering AG, Neuropsychopharmakology, Müllerstr. 178, 13352 Berlin, Germany

关键词: APP;    A4CT;    βA4;    Processing;    SY5Y;    Alzheimer's disease;   

DOI  :  10.1016/0014-5793(93)80446-2

学科分类：生物化学/生物物理

来源: John Wiley & Sons Ltd.

【 摘 要 】

The cellular mechanisms underlying the generation of βA4 in Alzheimer's disease and its relationship to the normal metabolism of the amyloid protein precursor (APP) are unknown. In this report, we show that expression of the C-terminal 100 residues of APP, with (SPA4CT) or without (A4CT) a signal sequence in the N-terminal position, in human neuroblastoma cells results in secretion of a 4 kDa βA4-like peptide. In A4CT and SPA4CT expressing SY5Y cells, βA4 generation could not be inhibited by the lysosomotropic amines chloroquine and ammonium chloride but was inhibited by brefeldin A, monensin and methylamine. The last also selectively inhibits APP secretion in neuroblastoma cells [1]. The finding that chloroquine and ammonium chloride inhibit βA4 generation from full length APP but not from A4CT and SPA4CT are consistent with the assumption that the two cleavages necessary to generate βA4 operate in two different compartments. Our data suggest the cleavage which generates the C-terminus of βA4 takes place in the same compartment (late Golgi or endosomal vesicles) in which the APP-secretase operates.

【 授权许可】

Unknown